Insulin Receptor β Antibody

About the Target

CD220 is a target of interest in many antibody-based workflows. Insulin receptor β (IR-β) is one of the two subunits forming the insulin receptor, a heterotetrameric protein complex consisting of two extracellular α-subunits and two transmembrane β-subunits. The β-subunit spans the cell membrane and includes an intracellular tyrosine kinase domain crucial for signal transduction. Upon insulin binding to the α-subunits, the receptor undergoes conformational changes that activate the β-subunit’s kinase domain through autophosphorylation of specific tyrosine residues. Depending on the literature source, CD220 may also be discussed as Insulin Receptor beta and Insulin receptor.

Reported cellular context includes cell membrane, endosome, lysosome, and membrane, which can matter when signal is compared across treatments or changing cell states. Following CD220 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CD220 is commonly interpreted in the context of immunology, metabolism, and endocrinology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, endosome, and lysosome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane, endosome, and lysosome across matched conditions
• context differences tied to immune-cell state, activation, or lineage composition
• responses linked to nutrient status, mitochondrial state, or metabolic rewiring
• responses to hormone-dependent signaling or endocrine feedback context

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CD220. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CD220 reflect biology rather than handling. When interpreting CD220, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CD220 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.